Respiratory News and Research

RSS

Tiger with SARS-CoV-2 infection demostrates reverse zoonosis

Some viruses come from animals and jump to humans to cause disease. In the case of the novel coronavirus, now known as the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), it is thought to have come from bats, jumped to an intermediate animal host, and then onto humans. But can the virus leap from humans to other animals?

6 Apr 2020

Antiparasitic drug Ivermectin kills coronavirus in 48 hours

Around the world, scientists race to develop a vaccine or treatment against the coronavirus disease (COVID-19), caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Now, a team of researchers has found that a drug already available around the world can kill the coronavirus in a lab setting in just 48 hours.

6 Apr 2020

Researchers create algorithm to protect surgical team members from COVID-19

Researchers from Stanford University's department of surgery have created an algorithm that aims to protect operating room team members who perform urgent and emergency operations from Coronavirus Disease 2019 (COVID-19) and rationally conserve the personal protective equipment they wear.

6 Apr 2020

McMaster: Common medical masks are good for most COVID-19 treatment

The N95 respirator masks should be preserved for health-care workers involved in inserting breathing tubes for patients with COVID-19. More common medical masks are fine for all other COVID-19 treatment, says preliminary research from McMaster University.

6 Apr 2020

Rush participates in clinical trial to test remdesivir as potential treatment for COVID-19

Rush University Medical Center is participating in a new clinical trial to test the effectiveness of the drug remdesivir in the treatment of coronavirus disease 2019 (COVID-19). This disease currently has no approved treatment.

6 Apr 2020

Cranfield University helps design simple, low-cost ventilators for critically-ill COVID-19 patients

A simple, low-cost Bag Valve Mask (BVM) ventilator to help critically-ill COVID-19 patients has been rapidly designed by experts at Cranfield University (UK) and built in Georgia Tech (USA) in a matter of days.

6 Apr 2020

Should US schools close to thwart spread of COVID-19?

A new study used mathematical modeling to explore the benefits and risks of closing down the schools to prevent new cases and the possibility of absenteeism among health care workers because they need to care for their children at home and the ultimate effect of the step on reducing the risk of deaths due to COVID-19.

6 Apr 2020

Experimental drug APN01 prevents COVID-19 infection in the lab

With the world gripped with the COVID-19 pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), there is a frantic rush to find an effective drug that can be used to treat the disease.

6 Apr 2020

ATS releases new guidance to help clinicians manage COVID-19 patients

An American Thoracic Society-led international task force has released a guidance document to help clinicians manage COVID-19 patients in the face of a worldwide pandemic and minimal empirical evidence to guide treatment.

6 Apr 2020

Researchers investigate link between air pollution and SARS-CoV-2 lethality in Italy

The world has been hit hard by coronavirus, and health services and authorities everywhere are struggling to reduce the spread, combat the disease and protect the population. Nevertheless, the pandemic will cost lives throughout the world.

6 Apr 2020

DsbA-L gene may play a role in protecting respiratory function of the elderly

The lungs are constantly exposed to the external environment and maintain homeostasis by adapting to stress and tissue damage.

6 Apr 2020

Acute-19 becomes first bi-level turbine ventilator for patients affected by COVID-19

The first prototype of a bi-level turbine ventilator for pressure-monitored ventilation in patients affected by COVID-19, Acute-19, developed by Spanish researchers, has just successfully surpassed the validation phase in an animal model at the CEU Cardenal Herrera University of Valencia.

6 Apr 2020

Wearing facemasks in public could help protect from COVID-19

Wearing a face-mask while out-and-about on public transport, in shops and in crowded places could help protect people from COVID-19 - according to new research from the University of East Anglia.

6 Apr 2020

GlobalData: Digital biomarkers emerging as key predictive tools to manage COVID-19 pandemic

Remote patient monitoring is accelerating the development and validation of digital biomarkers to help identify patients that are at risk from the coronavirus (COVID-19), supporting the assessment of disease progression and allowing continuous monitoring of disease symptoms, as well as providing data for new outbreaks, says GlobalData, a leading data and analytics company.

6 Apr 2020

Siemens Healthineers releases test kit for coronavirus COVID-19

Siemens Healthineers announced today the availability of its molecular Fast Track Diagnostics SARS-CoV-2 Assay test kit used to aid in the diagnosis of infection by the SARS-CoV-2 virus that causes the COVID-19 disease.

From Siemens Healthineers Point of Care Diagnostics 6 Apr 2020

Mysterious heart damage, not just lung troubles, befalling COVID-19 patients

While the focus of the COVID-19 pandemic has been on respiratory problems and securing enough ventilators, doctors on the front lines are grappling with a new medical mystery.

6 Apr 2020

Asthma and coronavirus disease - COVID-19

On the 11th of March 2020, the World Health Organization (WHO) declared COVID-19, caused by severe acute respiratory syndrome SARS CoV-2, a pandemic.

5 Apr 2020

COVID-19 and renin-angiotensin system inhibitors

A new viewpoint article published in the journal JAMA Network in April 2020 deals with the use of a widely used category of cardiovascular medications in COVID-19 patients with hypertension, diabetes, and cardiovascular disease (CVD). These are the most common medical conditions that are found in COVID-19 patients and contribute disproportionately to mortality.

5 Apr 2020

Clinical trial to evaluate experimental COVID-19 drug is underway at Montefiore and Einstein

Montefiore Health System and Albert Einstein College of Medicine has joined a clinical trial to evaluate the experimental drug remdesivir to treat people who are hospitalized with severe COVID-19 infection.

5 Apr 2020

Scientists show how normal speech may produce aerosolized particles to transmit coronavirus

Normal speech by individuals who are asymptomatic but infected with coronavirus may produce enough aerosolized particles to transmit the infection, according to aerosol scientists at the University of California, Davis.

5 Apr 2020